790404 | 18:1 DGS-NTA(Ni)
1,2-dioleoyl-sn-glycero-3-[(N-(5-amino-1-carboxypentyl)iminodiacetic acid)succinyl] (nickel salt)
18:1 DGS-NTA(Ni)
1,2-dioleoyl-sn-glycero-3-[(N-(5-amino-1-carboxypentyl)iminodiacetic acid)succinyl] (nickel salt)
CAS Registry Number is a Registered Trademark of the American Chemical Society
DOGS NTA
Sakamoto R, Tanabe M, Hiraiwa T, Suzuki K, Ishiwata S, Maeda YT, Miyazaki M. Tug-of-war between actomyosin-driven antagonistic forces determines the positioning symmetry in cell-sized confinement. Nat Commun. 2020 Jun 15;11(1):3063. doi: 10.1038/s41467-020-16677-9. PMID: 32541780; PMCID: PMC7295813.
PubMed ID: 32541780Xu X, Hou B, Fulzele A, Masubuchi T, Zhao Y, Wu Z, Hu Y, Jiang Y, Ma Y, Wang H, Bennett EJ, Fu G, Hui E. PD-1 and BTLA regulate T cell signaling differentially and only partially through SHP1 and SHP2. J Cell Biol. 2020 Jun 1;219(6):e201905085. doi: 10.1083/jcb.201905085. PMID: 32437509; PMCID: PMC7265324.
PubMed ID: 32437509Wang S, Li Y, Ma C. Atg3 promotes Atg8 lipidation via altering lipid diffusion and rearrangement. Protein Sci. 2020 Jun;29(6):1511-1523. doi: 10.1002/pro.3866. Epub 2020 Apr 20. PMID: 32277540; PMCID: PMC7255502.
PubMed ID: 32277540Lin JJ, O'Donoghue GP, Wilhelm KB, Coyle MP, Low-Nam ST, Fay NC, Alfieri KN, Groves JT. Membrane Association Transforms an Inert Anti-TCRβ Fab' Ligand into a Potent T Cell Receptor Agonist. Biophys J. 2020 Apr 23:S0006-3495(20)30341-6. doi: 10.1016/j.bpj.2020.04.018. Epub ahead of print. PMID: 32407684.
PubMed ID: 32407684Škerle J, Humpolíčková J, Johnson N, Rampírová P, Poláchová E, Fliegl M, Dohnálek J, Suchánková A, Jakubec D, Strisovsky K. Membrane Protein Dimerization in Cell-Derived Lipid Membranes Measured by FRET with MC Simulations. Biophys J. 2020 Apr 21;118(8):1861-1875. doi: 10.1016/j.bpj.2020.03.011. Epub 2020 Mar 29. PMID: 32246901; PMCID: PMC7175701.
PubMed ID: 32246901Yong X, Zhao L, Deng W, Sun H, Zhou X, Mao L, Hu W, Shen X, Sun Q, Billadeau DD, Xue Y, Jia D. Mechanism of cargo recognition by retromer-linked SNX-BAR proteins. PLoS Biol. 2020 Mar 9;18(3):e3000631. doi: 10.1371/journal.pbio.3000631. PMID: 32150533; PMCID: PMC7082075.
PubMed ID: 32150533Majzner RG, Rietberg SP, Sotillo E, Dong R, Vachharajani VT, Labanieh L, Myklebust JH, Kadapakkam M, Weber EW, Tousley AM, Richards RM, Heitzeneder S, Nguyen SM, Wiebking V, Theruvath J, Lynn RC, Xu P, Dunn AR, Vale RD, Mackall CL. Tuning the Antigen Density Requirement for CAR T Cell Activity. Cancer Discov. 2020 Mar 19:CD-19-0945. doi: 10.1158/2159-8290.CD-19-0945. Epub ahead of print. PMID: 32193224.
PubMed ID: 32193224Das DK, Bulow U, Diehl WE, Durham ND, Senjobe F, Chandran K, Luban J, Munro JB. Conformational changes in the Ebola virus membrane fusion machine induced by pH, Ca2+, and receptor binding. PLoS Biol. 2020 Feb 10;18(2):e3000626. doi: 10.1371/journal.pbio.3000626. PMID: 32040508; PMCID: PMC7034923.
PubMed ID: 32040508Farell M, Self A, Guza C, Song H, Apollon L, Gomez EW, Kumar M. Lipid-Functionalized Graphene Loaded with hMnSOD for Selective Inhibition of Cancer Cells. ACS Appl Mater Interfaces. 2020 Mar 18;12(11):12407-12416. doi: 10.1021/acsami.9b20070. Epub 2020 Mar 6. PMID: 32077682.
PubMed ID: 32077682Steinkühler J, Knorr RL, Zhao Z, Bhatia T, Bartelt SM, Wegner S, Dimova R, Lipowsky R. Controlled division of cell-sized vesicles by low densities of membrane-bound proteins. Nat Commun. 2020 Feb 14;11(1):905. doi: 10.1038/s41467-020-14696-0. PMID: 32060284; PMCID: PMC7021675.
PubMed ID: 32060284Togo S, Sato K, Kawamura R, Kobayashi N, Noiri M, Nakabayashi S, Teramura Y, Yoshikawa HY. Quantitative evaluation of the impact of artificial cell adhesion via DNA hybridization on E-cadherin-mediated cell adhesion. APL Bioeng. 2020 Jan 27;4(1):016103. doi: 10.1063/1.5123749. PMID: 32002498; PMCID: PMC6984976.
PubMed ID: 32002498Orrell KE, Mansfield MJ, Doxey AC, Melnyk RA. The C. difficile toxin B membrane translocation machinery is an evolutionarily conserved protein delivery apparatus. Nat Commun. 2020 Jan 23;11(1):432. doi: 10.1038/s41467-020-14306-z. PMID: 31974369; PMCID: PMC6978384.
PubMed ID: 31974369Petroková H, Mašek J, Kuchař M, Vítečková Wünschová A, Štikarová J, Bartheldyová E, Kulich P, Hubatka F, Kotouček J, Knotigová PT, Vohlídalová E, Héžová R, Mašková E, Macaulay S, Dyr JE, Raška M, Mikulík R, Malý P, Turánek J. Targeting Human Thrombus by Liposomes Modified with Anti-Fibrin Protein Binders. Pharmaceutics. 2019 Dec 2;11(12):642. doi: 10.3390/pharmaceutics11120642. PMID: 31810280; PMCID: PMC6955937.
PubMed ID: 31810280De Miguel D, Gallego-Lleyda A, Martinez-Ara M, Plou J, Anel A, Martinez-Lostao L. Double-Edged Lipid Nanoparticles Combining Liposome-Bound TRAIL and Encapsulated Doxorubicin Showing an Extraordinary Synergistic Pro-Apoptotic Potential. Cancers (Basel). 2019 Dec 5;11(12):E1948. doi: 10.3390/cancers11121948. PMID: 31817469.
PubMed ID: 31817469Ryu JY, Won EJ, Lee HAR, et al. Ultrasound-activated particles as CRISPR/Cas9 delivery system for androgenic alopecia therapy [published online ahead of print, 2019 Dec 28]. Biomaterials. 2019;232:119736. doi:10.1016/j.biomaterials.2019.119736
PubMed ID: 31901692Zhao Y, Lee CK, Lin CH, Gassen RB, Xu X, Huang Z, Xiao C, Bonorino C, Lu LF, Bui JD, Hui E. PD-L1:CD80 Cis-Heterodimer Triggers the Co-stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 Pathways. Immunity. 2019 Dec 17;51(6):1059-1073.e9. doi: 10.1016/j.immuni.2019.11.003. Epub 2019 Nov 19.
PubMed ID: 31757674Dürre K, Bausch AR. Formation of phase separated vesicles by double layer cDICE. Soft Matter. 2019 Dec 4;15(47):9676-9681. doi: 10.1039/c8sm02491j.
PubMed ID: 31663090Suleiman E, Damm D, Batzoni M Temchura V, Wagner A, Überla K, Vorauer-Uhl K. Electrostatically Driven Encapsulation of Hydrophilic, Non-Conformational Peptide Epitopes into Liposomes. Pharmaceutics. 2019 Nov 18;11(11). pii: E619. doi: 10.3390/pharmaceutics11110619.
PubMed ID: 31752070Raghunath G, Dyer RB. Kinetics of Histidine-Tagged Protein Association to Nickel-Decorated Liposome Surfaces. Langmuir. 2019 Sep 24;35(38):12550-12561. doi: 10.1021/acs.langmuir.9b01700. Epub 2019 Sep 9.
PubMed ID: 31466440Sasmal DK, Feng W, Roy S, Leung P, He Y, Cai C, Cao G, Lian H, Qin J, Hui E, Schreiber H, Adams EJ, Huang J. TCR-pMHC bond conformation controls TCR ligand discrimination. Cell Mol Immunol. 2019 Sep 17. doi: 10.1038/s41423-019-0273-6. [Epub ahead of print]
PubMed ID: 31530899Gao S, Tian B, Han J, Zhang J, Shi Y, Lv Q, Li K. Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema. Int J Nanomedicine. 2019 Aug 2;14:6135-6150. doi: 10.2147/IJN.S205295. eCollection 2019.
PubMed ID: 31447556Jyotsana N, Zhang Z, Himmel LE, Yu F, King MR. Minimal dosing of leukocyte targeting TRAIL decreases triple-negative breast cancer metastasis following tumor resection. Sci Adv. 2019 Jul 24;5(7):eaaw4197. doi: 10.1126/sciadv.aaw4197. eCollection 2019 Jul.
PubMed ID: 31355333Liu J, Zhu L, Zhang X, Wu B, Zhu P, Zhao H, Wang J. Peptide-based NTA(Ni)-nanodiscs for studying membrane enhanced FGFR1 kinase activities. PeerJ. 2019 Jul 23;7:e7234. doi: 10.7717/peerj.7234. eCollection 2019.
PubMed ID: 31372315Dang AT, He W, Ivey DB, Coleman MA, Kuhl TL. Lipid and Protein Transfer between Nanolipoprotein Particles and Supported Lipid Bilayers. Langmuir. 2019 Sep 6. doi: 10.1021/acs.langmuir.9b01288. [Epub ahead of print]
PubMed ID: 31442053Zeno WF, Thatte AS, Wang L, Snead WT, Lafer EM, Stachowiak JC. Molecular Mechanisms of Membrane Curvature Sensing by a Disordered Protein. J Am Chem Soc. 2019 Jul 3;141(26):10361-10371. doi: 10.1021/jacs.9b03927. Epub 2019 Jun 20.
PubMed ID: 31180661Mintz MA, Felce JH, Chou MY, Mayya V, Xu Y, Shui JW, An J, Li Z, Marson A, Okada T, Ware CF, Kronenberg M, Dustin ML, Cyster JG. The HVEM-BTLA Axis Restrains T Cell Help to Germinal Center B Cells and Functions as a Cell-Extrinsic Suppressor in Lymphomagenesis. Immunity. 2019 Jun 10. pii: S1074-7613(19)30242-0. doi: 10.1016/j.immuni.2019.05.022. [Epub ahead of print]
PubMed ID: 31204070Kashefi M, Malik N, Struppe JO, Thompson LK. Carbon-nitrogen REDOR to identify ms-timescale mobility in proteins. J Magn Reson. 2019 May 23;305:5-15. doi: 10.1016/j.jmr.2019.05.008. [Epub ahead of print]
PubMed ID: 31158793Xia C, Shen AL, Duangkaew P, Kotewong R, Rongnoparut P, Feix J, Kim JP. Structural and Functional Studies of the Membrane-Binding Domain of NADPH-Cytochrome P450 Oxidoreductase. Biochemistry. 2019 May 14;58(19):2408-2418. doi: 10.1021/acs.biochem.9b00130. Epub 2019 May 1.
PubMed ID: 31009206Drennan AC, Krishna S, Seeger MA, Andreas MP, Gardner JM, Sether EKR, Jaspersen SL, Rayment I. Structure and function of Spc42 coiled-coils in yeast centrosome assembly and duplication. Mol Biol Cell. 2019 Apr 10:mbcE19030167. doi: 10.1091/mbc.E19-03-0167. [Epub ahead of print]
PubMed ID: 30969903Valverde D, Yu, Boggavarapu V, Kumar N, Lees JA, Walz T, Reinisch KM, Melia TJ. ATG2 transports lipids to promote autophagosome biogenesis. J Cell Biol. 2019 Apr 5. pii: jcb.201811139. doi: 10.1083/jcb.201811139. [Epub ahead of print]
PubMed ID: 30952800Colin-York H, Javanmardi Y, Skamrahl M, Kumari S, Chang VT, Khuon S, Taylor A, Chew TL, Betzig E, Moeendarbary E, Cerundolo V, Eggeling C, Fritzsche M. Cytoskeletal Control of Antigen-Dependent T Cell Activation. Cell Rep. 2019 Mar 19;26(12):3369-3379.e5. doi: 10.1016/j.celrep.2019.02.074.
PubMed ID: 30893608Jamecna D, Polidori J, Mesmin B, Dezi M, Levy D, Bigay J, Antonny B. An Intrinsically Disordered Region in OSBP Acts as an Entropic Barrier to Control Protein Dynamics and Orientation at Membrane Contact Sites. Dev Cell. 2019 Mar 16. pii: S1534-5807(19)30144-3. doi: 10.1016/j.devcel.2019.02.021. [Epub ahead of print]
PubMed ID: 30905771Camille Simon, Rémy Kusters, Valentina Caorsi, Antoine Allard, Majdouline Abou-Ghali, John Manzi, Aurélie Di Cicco, Daniel Lévy, Martin Lenz, Jean-François Joanny, Clément Campillo, Julie Plastino, Pierre Sens, and Cécile Sykes. Actin dynamics drive cell-like membrane deformation. Nature Physics. 2019 March 18. doi: 10.1038/s41567-019-0464-1
Bian X, De Camilli P. In Vitro Assays to Measure the Membrane Tethering and Lipid Transport Activities of the Extended Synaptotagmins. Methods Mol Biol. 2019;1949:201-212. doi: 10.1007/978-1-4939-9136-5_15.
PubMed ID: 30790258Chalupska D, Różycki B, Humpolickova J, Faltova L, Klima M, Boura E. Phosphatidylinositol 4-kinase IIIβ (PI4KB) forms highly flexible heterocomplexes that include ACBD3, 14-3-3, and Rab11 proteins. Sci Rep. 2019 Jan 24;9(1):567. doi: 10.1038/s41598-018-37158-6.
PubMed ID: 30679637Cho EY, Ryu JY, Lee HAR, Hong SH, Park HS, Hong KS, Park SG, Kim HP, Yoon TJ. Lecithin nano-liposomal particle as a CRISPR/Cas9 complex delivery system for treating type 2 diabetes. J Nanobiotechnology. 2019 Jan 29;17(1):19. doi: 10.1186/s12951-019-0452-8.
PubMed ID: 30696428Dong J, Du X, Wang H, Wang J, Lu C, Chen X, Zhu Z, Luo Z, Yu L, Brown AJ, Yang H, Wu JW. Allosteric enhancement of ORP1-mediated cholesterol transport by PI(4,5)P2/PI(3,4)P2. Nat Commun. 2019 Feb 19;10(1):829. doi: 10.1038/s41467-019-08791-0.
PubMed ID: 30783101Koponen A, Arora A, Takahashi K, Kentala H, Kivelä AM, Jääskeläinen E, Peränen J, Somerharju P, Ikonen E, Viitala T, Olkkonen VM. ORP2 interacts with phosphoinositides and controls the subcellular distribution of cholesterol. Biochimie. 2019 Mar;158:90-101. doi: 10.1016/j.biochi.2018.12.013. Epub 2018 Dec 24.
PubMed ID: 30590084Lin JJY, Low-Nam ST, Alfieri KN, McAffee DB, Fay NC, Groves JT. Mapping the stochastic sequence of individual ligand-receptor binding events to cellular activation: T cells act on the rare events. Sci Signal. 2019 Jan 15;12(564). pii: eaat8715. doi: 10.1126/scisignal.aat8715.
PubMed ID: 30647147M. J. Rodrigues-Jesus, W. L. Fotoran, R. M. Cardoso, K. Araki, G. Wunderlich, Luís C. S. Ferreira. Nano-multilamellar lipid vesicles (NMVs) enhance protective antibody responses against Shiga toxin (Stx2a) produced by enterohemorrhagic Escherichia coli strains (EHEC). Braz J Microbiol. 2019 Jan;50(1):67-77. doi: 10.1007/s42770-018-0035-0. Epub 2018 Dec 6.
PubMed ID: 30637647Mandal T, Hustedt EJ, Song L, Oh KJ. CW EPR and DEER Methods to Determine BCL-2 Family Protein Structure and Interactions: Application of Site-Directed Spin Labeling to BAK Apoptotic Pores. Methods Mol Biol. 2019;1877:257-303. doi: 10.1007/978-1-4939-8861-7_18.
PubMed ID: 30536012Bazzill JD, Stronsky SM, Kalinyak LC, Ochyl LJ, Steffens JT, van Tongeren SA, Cooper CL, Moon JJ. Vaccine nanoparticles displaying recombinant Ebola virus glycoprotein for induction of potent antibody and polyfunctional T cell responses. Nanomedicine. 2018 Nov 22. pii: S1549-9634(18)30556-2. doi: 10.1016/j.nano.2018.11.005. [Epub ahead of print].
PubMed ID: 30471480Thomas LL, van der Vegt SA, Fromme JC. A Steric Gating Mechanism Dictates the Substrate Specificity of a Rab-GEF. Dev Cell. 2019 Jan 7;48(1):100-114.e9. doi: 10.1016/j.devcel.2018.11.013. Epub 2018 Dec 6.
PubMed ID: 30528786Maan R, Loiseau E, Bausch AR. Adhesion of Active Cytoskeletal Vesicles. Biophys J. 2018 Dec 18;115(12):2395-2402. doi: 10.1016/j.bpj.2018.10.013. Epub 2018 Oct 23.
PubMed ID: 30455042Chen Z, Moon JJ, Cheng W. Quantitation and Stability of Protein Conjugation on Liposomes for Controlled Density of Surface Epitopes. Bioconjug Chem. 2018 Mar 19. doi: 10.1021/acs.bioconjchem.8b00033.
PubMed ID: 29528624Zhang, H., Shen, W., Rempel, D., Monsey, J., Vidavsky, I., Gross, M.L., Bose, R. (2011) Carboxyl-group footprinting maps the dimerization interface and phosphorylation-induced conformational changes of a membrane-associated tyrosine kinase. Mol Cell Proteomics. 10:M110.005678. [PubMed]
PubMed ID: 21422241Merrill, S.A., Hanson, P.I. (2010) Activation of human VPS4A by ESCRT-III proteins reveals ability of substrates to relieve enzyme autoinhibition. J Biol Chem. 285:35428-38. [PubMed]
PubMed ID: 20805225Monsey, J., Shen, W., Schlesinger, P., Bose, R. (2009) Her4 and Her2/neu tyrosine kinase domains dimerize and activate in a reconstituted in vitro system. J Biol Chem epublished December 18, 2009. [Abstract]
PubMed ID: 20022944Montefusco, D.J., Asinas, A.E., Weis, R.M. (2007) Liposome-mediated assembly of receptor signaling complexes. Methods Enzymol 423:267-298. [PubMed]
PubMed ID: 17609136Zhang, X., Gureasko, J., Shen, K., Cole, P.A., Kuriyan, J. (2006) An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell 125:1137-1149. [PubMed]
PubMed ID: 16777603Shrout, A.L., Montefusco, D.J., Weis, R.M. (2003) Template-directed assembly of receptor signaling complexes. Biochemistry 42:13379-13385. [PubMed]
PubMed ID: 14621982Dryden, K.A., C.S. Crowley, S. Tanaka, T.O. Yeates, and M. Yeager. (2009).Two-dimensional crystals of carboxysome shell proteins recapitulate the hexagonal packing of three-dimensional crystals. Protein Sci 18:2629-35. [PubMed]
PubMed ID: 19844993Abeyrathnea, P.D., Chamia, M., Pantelica, R.S., Goldiea, K.N., Stahlberga, H. (2010) Preparation of 2D Crystals of Membrane Proteins for High-Resolution Electron Crystallography Data Collection. Methods Enzymol. 481:25-43. [PubMed]
PubMed ID: 20887851Wilson-Kubalek, E.M., Chappie, J.S., Arthur, C.P. (2010) Helical crystallization of soluble and membrane binding proteins. Methods Enzymol. 481:45-62. [PubMed]
PubMed ID: 20887852Dang, T.X., Milligan, R.A., Tweten, R.K., Wilson-Kubalek, E.M. (2005) Helical crystallization on nickel-lipid nanotubes: perfringolysin O as a model protein. J Struct Biol. 152:129-39. [PubMed]
PubMed ID: 16242343Kubalek, E., LeGrice, S.F.J., Brown, P. (1994) Two-dimensional crystallization of histidine-tagged HIV-1 reverse transcriptase promoted by a novel nickel-chelating lipid. J. Struct. Biol. 113:117-123. [Pubmed]
PubMed ID: 7536435Schmitt, L., Dietrich, L., Tampé, R.J. (1994) Synthesis and characterization of chelator-lipids for reversible immobilization of engineered proteins at self-assembled lipid interfaces. Am. Chem. Soc. 116:8485-8491. [JACS]
Dietrich, C., Boscheinen, O., Scharf, K-D., Schmitt, L., Tampé, R. (1996) Functional immobilization of a DNA-binding protein at a membrane interface via histidine tag and synthetic chelator lipids. Biochemistry 35:1100-1105. [Pubmed]
PubMed ID: 8573564Barklis, E., McDermott, J., Wilkens, S., Schabtach, E., Schmid, M.F., Fuller, S., Karanjia, S., Love, Z., Jones, R., Rui, Y., Zhao, X., Thompson, D. (1997) Structural analysis of membrane-bound retrovirus capsid proteins. EMBO J. 16:1199-1213. [Pubmed]
PubMed ID: 9135137Vénien-Bryan, C., Balavoine, F., Toussaaint, B., Miskowski, C., Hewat, E.A., Helme, B., Vignais, P.M. (1997) Structural study of the response regulator HupR from Rodobacter capsulatus. Electron microscopy of two-dimensional crystals on a nickel-chelating lipid. J. Mol. Biol. 274:687-692. [Pubmed]
PubMed ID: 9405151Bischler, N., Balavoine, F., Milkereit, P., Tschochner, H., Mioskowski, C., Schultz, P. (1998) Specific interaction and two-dimensional crystallization of histidine tagged yeast RNA polymerase I on nickel-chelating lipids. Biophys. J. 74:1522-1532. [Pubmed]
PubMed ID: 9512048Barklis, E., McDermott, J., Wilkens, S., Fuller, S., Thompson, D. (1998) Organization of HIV-1 capsid proteins on a lipid monolayer. J. Biol. Chem. 273:7177-7180. [Pubmed]
PubMed ID: 9516405Vénien-Bryan, C., Lenne, P-F., Zakri, C., Renault, A., Brisson, A., Legrand, J-F., Berge, B. (1998) Characterization of the growth of 2D protein crystals on a lipid monolayer by ellipsometry and rigidity measurements coupled to electron microscopy. Biophysical J. 74:2649-2657. [Pubmed]
PubMed ID: 9591688Wilson-Kubalek, E.M., Brown, R.E., Celia, H., Milligan, R.A. (1998) Lipid nanotubes as substrates for helical crystallization of macromolecules. Proc. Natl. Acad. Sci. USA 95:8040-8045. [Pubmed]
PubMed ID: 9653136- Certificate of Analysis (Lot No. 790404C-10MG-A-089 and 5244CIA089)
- Certificate of Analysis (Lot No. 790404C-25MG-A-089 and 5244CJA089)
- Certificate of Analysis (Lot No. 790404C-5MG-A-089 and 5244CHA089)
- Certificate of Analysis (Lot No. 790404P-10MG-A-089 and 5244PIA089)
- Certificate of Analysis (Lot No. 790404P-25MG-A-089 and 5244PJA089)
- Certificate of Analysis (Lot No. 790404P-5MG-A-089 and 5244PHA089)
- Certificate of Analysis (Lot No. 790404C-5MG-A-091 and 5244CHA091)
- Certificate of Analysis (Lot No. 790404C-5MG-A-092 and 5244CHA092)
- Certificate of Analysis (Lot No. 790404P-25MG-A-092 and 5244PJA092)
- Certificate of Analysis (Lot No. 790404P-10MG-A-092 and 5244PIA092)
- Certificate of Analysis (Lot No. 790404P-5MG-A-092 and 5244PHA092)
- Certificate of Analysis (Lot No. 790404C-10MG-A-093 and 5244CIA093)
- Certificate of Analysis (Lot No. 790404C-25MG-A-093 and 5244CJA093)
- Certificate of Analysis (Lot No. 790404P-25MG-A-093 and 5244PJA093)
- Certificate of Analysis (Lot No. 790404C-5MG-A-093 and 5244CHA093)
- Certificate of Analysis (Lot No. 790404P-10MG-A-093 and 5244PIA093)
- Certificate of Analysis (Lot No. 790404C-25MG-A-094 and 5244CJA094)
- Certificate of Analysis (Lot No. 790404P-5MG-A-094 and 5244PHA094)
- Certificate of Analysis (Lot No. 790404C-5MG-A-094 and 5244CHA094)
- Certificate of Analysis (Lot No. 790404C-10MG-A-094 and 5244CIA094)
- Certificate of Analysis (Lot No. 790404P-25MG-A-094 and 5244PJA094)
- Certificate of Analysis (Lot No. 790404C-5MG-B-094 and 5244CHB094)
- Certificate of Analysis (Lot No. 790404P-10MG-A-094 and 5244PIA094)
- Certificate of Analysis (Lot No. 790404P-5MG-B-094 and 5244PHB094)
- Certificate of Analysis (Lot No. 790404C-10MG-A-096 and 5244CIA096)
- Certificate of Analysis (Lot No. 790404C-5MG-A-096 and 5244CHA096)
- Certificate of Analysis (Lot No. 790404P-10MG-A-096 and 5244PIA096)
- Certificate of Analysis (Lot No. 790404C-CONF-A-094 and 5244CWA094)
- Certificate of Analysis (Lot No. 790404C-100MG-A-097 and 5244CIA097)
- Certificate of Analysis (Lot No. 790404P-25MG-A-097 and 5244PJA097)
- Certificate of Analysis (Lot No. 790404C-5MG-A-097 and 5244CHA097)
- Certificate of Analysis (Lot No. 790404P-25MG-B-097 and 5244PJB097)
- Certificate of Analysis (Lot No. 790404C-25MG-A-097 and 5244CJA097)
- Certificate of Analysis (Lot No. 790404P-10MG-A-097 and 5244PIA097)
- Certificate of Analysis (Lot No. 790404P-5MG-A-098 and 5244PHA098)
- Certificate of Analysis (Lot No. 790404P-10MG-A-098 and 5244PIA098)
- Certificate of Analysis (Lot No. 790404C-5MG-A-098 and 5244CHA098)
- Certificate of Analysis (Lot No. 790404P-5MG-B-098 and 5244PHB098)
- Certificate of Analysis (Lot No. 790404C-25MG-A-098 and 5244CJA098)
- Certificate of Analysis (Lot No. 790404P-5MG-C-098 and 5244PHC098)
- Certificate of Analysis (Lot No. 790404C-5MG-B-098 and 5244CHB098)
- Certificate of Analysis (Lot No. 790404C-5MG-C-098 and 5244CHC098)
- Certificate of Analysis (Lot No. 790404C-25MG-A-099 and 5244CJA099)
- Certificate of Analysis (Lot No. 790404P-10MG-A-099 and 5244PIA099)
- Certificate of Analysis (Lot No. 790404P-5MG-A-099 and 5244PHA099)
- Certificate of Analysis (Lot No. 790404C-10MG-A-099 and 5244CIA099)
- Certificate of Analysis (Lot No. 790404C-5MG-A-103 and 5244CHA103)
- Certificate of Analysis (Lot No. 790404P-5MG-A-103 and 5244PHA103)
- Certificate of Analysis (Lot No. 790404C-10MG-A-103 and 5244CIA103)
- Certificate of Analysis (Lot No. 790404P-25MG-A-105 and 5244PJA105)
- Certificate of Analysis (Lot No. 790404C-5MG-A-105 and 5244CHA105)
- Certificate of Analysis (Lot No. 790404P-25MG-A-104 and 5244PJA104)
- Certificate of Analysis (Lot No. 790404P-5MG-A-106 and 5244PHA106)
- Certificate of Analysis (Lot No. 790404P-5MG-A-104 and 5244PHA104)
- Certificate of Analysis (Lot No. 790404P-5MG-A-101 and 5244PHA101)
- Certificate of Analysis (Lot No. 790404C-25MG-A-106 and 5244CJA106)
- Certificate of Analysis (Lot No. 790404C-5MG-B-105 and 5244CHB105)
- Certificate of Analysis (Lot No. 790404P-25MG-A-107 and 5244PJA107)
- Certificate of Analysis (Lot No. 790404P-25MG-A-104 and 5244PJA104)
- Certificate of Analysis (Lot No. 790404P-5MG-A-106 and 5244PHA106)
- Certificate of Analysis (Lot No. 790404P-25MG-A-101 and 5244PJA101)
- Certificate of Analysis (Lot No. 790404P-10MG-A-101 and 5244PIA101)
- Certificate of Analysis (Lot No. 790404C-10MG-A-107 and 5244CIA107)
- Certificate of Analysis (Lot No. 790404C-5MG-D-104 and 5244CHD104)
- Certificate of Analysis (Lot No. 790404C-10MG-C-107 and 5244CIC107)
- Certificate of Analysis (Lot No. 790404C-10MG-B-107 and 5244CIB107)
- Certificate of Analysis (Lot No. 790404C-10MG-D-107 and 5244CID107)
- Certificate of Analysis (Lot No. 790404C-25MG-A-104 and 5244CJA104)
- Certificate of Analysis (Lot No. 790404C-25MG-A-107 and 5244CJA107)
- Certificate of Analysis (Lot No. 790404C-5MG-A-106 and 5244CHA106)
- Certificate of Analysis (Lot No. 790404C-10MG-F-107 and 5244CIF107)
- Certificate of Analysis (Lot No. 790404C-10MG-E-107 and 5244CIE107)
- Certificate of Analysis (Lot No. 790404C-10MG-A-105 and 5244CIA105)
- Certificate of Analysis (Lot No. 790404C-5MG-A-108 and 5244CHA108)
- Certificate of Analysis (Lot No. 790404P-5MG-A-108 and 5244PHA108)
- Certificate of Analysis (Lot No. 790404C-25MG-A-108 and 5244CJA108)
- Certificate of Analysis (Lot No. 790404C-10MG-A-108 and 5244CIA108)
- Certificate of Analysis (Lot No. 790404P-10MG-A-108 and 5244PIA108)
- Certificate of Analysis (Lot No. 790404P-25MG-A-109 and 5244PJA109)
- Certificate of Analysis (Lot No. 790404C-25MG-A-109 and 5244CJA109)
- Certificate of Analysis (Lot No. 790404C-5MG-A-109 and 5244CHA109)
- Certificate of Analysis (Lot No. 790404P-25MG-C-109 and 5244PJC109)
- Certificate of Analysis (Lot No. 790404P-25MG-B-109 and 5244PJB109)
- Certificate of Analysis (Lot No. 790404P-10MG-B-109 and 5244PIB109)
- Certificate of Analysis (Lot No. 790404P-10MG-A-109 and 5244PIA109)
- Certificate of Analysis (Lot No. 790404P-5MG-A-109 and 5244PHA109)
- Certificate of Analysis (Lot No. 790404C-25MG-B-109 and 5244CJB109)
- Certificate of Analysis (Lot No. 790404C-10MG-B-109 and 5244CIB109)
- Certificate of Analysis (Lot No. 790404C-10MG-A-109 and 5244CIA109)
- Certificate of Analysis (Lot No. 790404C-5MG-B-109 and 5244CHB109)
- Certificate of Analysis (Lot No. 790404P-10MG-B-111 and 5244PIB111)
- Certificate of Analysis (Lot No. 790404P-10MG-A-111 and 5244PIA111)
- Certificate of Analysis (Lot No. 790404P-5MG-C-111 and 5244PHC111)
- Certificate of Analysis (Lot No. 790404C-25MG-B-111 and 5244CJB111)
- Certificate of Analysis (Lot No. 790404C-25MG-A-111 and 5244CJA111)
- Certificate of Analysis (Lot No. 790404C-10MG-A-111 and 5244CIA111)
- Certificate of Analysis (Lot No. 790404C-5MG-C-111 and 5244CHC111)
- Certificate of Analysis (Lot No. 790404C-5MG-B-111 and 5244CHB111)
- Certificate of Analysis (Lot No. 790404C-5MG-A-111 and 5244CHA111)
- Certificate of Analysis (Lot No. 790404C-10MG-B-111 and 5244CIB111)
- Certificate of Analysis (Lot No. 790404C-25MG-A-112 and 5244CJA112)
- Certificate of Analysis (Lot No. 790404P-5MG-A-112 and 5244PHA112)
- Certificate of Analysis (Lot No. 790404P-5MG-B-111 and 5244PHB111)
- Certificate of Analysis (Lot No. 790404P-10MG-A-112 and 5244PIA112)
- Certificate of Analysis (Lot No. 790404P-25MG-A-111 and 5244PJA111)
- Certificate of Analysis (Lot No. 790404P-25MG-A-112 and 5244PJA112)
- Certificate of Analysis (Lot No. 790404P-25MG-B-112 and 5244PJB112)
- Certificate of Analysis (Lot No. 790404C-10MG-A-114 and 5244CIA114)
- Certificate of Analysis (Lot No. 790404P-5MG-C-113 and 5244PHC113)
- Certificate of Analysis (Lot No. 790404P-25MG-A-114 and 5244PJA114)
- Certificate of Analysis (Lot No. 790404C-5MG-C-113 and 5244CHC113)
- Certificate of Analysis (Lot No. 790404P-25MG-C-113 and 5244PJC113)
- Certificate of Analysis (Lot No. 790404C-5MG-B-113 and 5244CHB113)
- Certificate of Analysis (Lot No. 790404P-5MG-A-105 and 5244PHA105)
- Certificate of Analysis (Lot No. 790404P-5MG-A-113 and 5244PHA113)
- Certificate of Analysis (Lot No. 790404P-5MG-B-113 and 5244PHB113)
- Certificate of Analysis (Lot No. 790404P-10MG-A-105 and 5244PIA105)
- Certificate of Analysis (Lot No. 790404P-10MG-A-113 and 5244PIA113)
- Certificate of Analysis (Lot No. 790404P-25MG-A-113 and 5244PJA113)
- Certificate of Analysis (Lot No. 790404P-25MG-B-113 and 5244PJB113)
- Certificate of Analysis (Lot No. 790404P-25MG-C-113 and 5244PJC113)
- Certificate of Analysis (Lot No. 790404C-5MG-A-112 and 5244CHA112)
- Certificate of Analysis (Lot No. 790404C-5MG-B-112 and 5244CHB112)
- Certificate of Analysis (Lot No. 790404P-5MG-B-112 and 5244PHB112)
- Certificate of Analysis (Lot No. 790404C-10MG-A-110 and 5244CIA110)
- Certificate of Analysis (Lot No. 790404C-25MG-A-110 and 5244CJA110)
- Certificate of Analysis (Lot No. 790404C-25MG-B-110 and 5244CJB110)
- Certificate of Analysis (Lot No. 790404C-25MG-C-110 and 5244CJC110)
- Certificate of Analysis (Lot No. 790404P-5MG-A-110 and 5244PHA110)
- Certificate of Analysis (Lot No. 790404C-5MG-C-112 and 5244CHC112)
- Certificate of Analysis (Lot No. 790404C-10MG-B-112 and 5244CIB112)
- Certificate of Analysis (Lot No. 790404C-25MG-B-112 and 5244CJB112)
- Certificate of Analysis (Lot No. 790404C-25MG-C-112 and 5244CJC112)
- Certificate of Analysis (Lot No. 790404P-25MG-D-112 and 5244PJD112)
- Certificate of Analysis (Lot No. 790404C-5MG-A-113 and 5244CHA113)
- Certificate of Analysis (Lot No. 790404C-10MG-A-112 and 5244CIA112)
- Certificate of Analysis (Lot No. 790404C-10MG-A-113 and 5244CIA113)
- Certificate of Analysis (Lot No. 790404C-25MG-A-113 and 5244CJA113)
- Certificate of Analysis (Lot No. 790404P-25MG-C-112 and 5244PJC112)
- Certificate of Analysis (Lot No. 790404C-5MG-A-114 and 5244CHA14)
- Certificate of Analysis (Lot No. 790404C-25MG-A-114 and 5244CJA114)
- Certificate of Analysis (Lot No. 790404P-10MG-A-114 and 5244PIA114)
- Certificate of Analysis (Lot No. 790404C-5MG-A-115 and 5244CHA115)
- Certificate of Analysis (Lot No. 790404C-10MG-A-115 and 5244CIA115)
- Certificate of Analysis (Lot No. 790404P-25MG-A-115 and 5244PJA115)
- Certificate of Analysis (Lot No. 790404C-5MG-B-115 and 5244CHB115)
- Certificate of Analysis (Lot No. 790404C-25MG-A-115 and 5244CJA115)
- Certificate of Analysis (Lot No. 790404P-10MG-A-115 and 5244PIA115)
- Certificate of Analysis (Lot No. 790404C-10MG-B-115 and 5244CIB115)
- Certificate of Analysis (Lot No. 790404C-5MG-A-116 and 5244CHA116)
- Certificate of Analysis (Lot No. 790404C-25MG-A-116 and 5244CJA116)
- Certificate of Analysis (Lot No. 790404C-10MG-A-116 and 5244CIA116)
- Certificate of Analysis (Lot No. 790404P-5MG-A-116 and 5244PHA116)
- Certificate of Analysis (Lot No. 790404P-10MG-A-116 and 5244PIA116)
- Certificate of Analysis (Lot No. 790404P-25MG-A-116 and 5244PJA116)
- Certificate of Analysis (Lot No. 790404P-25MG-B-115 and 5244PJB115)
- Certificate of Analysis (Lot No. 790404C-5MG-B-116 and 5244CHB116)
- Certificate of Analysis (Lot No. 790404C-10MG-A-117 and 5244CIA117)
- Certificate of Analysis (Lot No. 790404C-25MG-A-117 and 5244CJA117)